Improved Outcomes with Low-Dose Hypomethylating Agent Plus Venetoclax As Post-Transplant Maintenance in Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Kendall Diebold, Todd William Mudd, Maris Hardee, Haley B. Thigpen, Manuel Ricardo Espinoza-Gutarra, Antonio Di Stasi, Donna E. Salzman, Razan Mohty, Ravi Bhatia, OMER HASSAN JAMY
DOI: 10.1016/j.jtct.2025.12.563
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Acute Myeloid Leukemia Research Chronic Myeloid Leukemia Treatments

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S392–S393
Publication date
1 February 2026
Language
EN